These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28087325)

  • 1. Does size really matter?: Relationship of particle size to lung deposition and exhaled fraction.
    Jabbal S; Poli G; Lipworth B
    J Allergy Clin Immunol; 2017 Jun; 139(6):2013-2014.e1. PubMed ID: 28087325
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional particle size dependent deposition of inhaled aerosols in rats and mice.
    Kuehl PJ; Anderson TL; Candelaria G; Gershman B; Harlin K; Hesterman JY; Holmes T; Hoppin J; Lackas C; Norenberg JP; Yu H; McDonald JD
    Inhal Toxicol; 2012 Jan; 24(1):27-35. PubMed ID: 22145784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of exhaled particles from the human lungs in airway obstruction.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):52-8. PubMed ID: 24914577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aerosol therapy].
    Sheina AN; Shchelkodin PI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1994; (3):32-5. PubMed ID: 7941475
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide.
    Marini S; Buonanno G; Stabile L; Ficco G
    Toxicol Appl Pharmacol; 2014 Jul; 278(1):9-15. PubMed ID: 24732441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted Deposition of E-Cigarette Aerosol in the Human Lungs.
    Sosnowski TR; Kramek-Romanowska K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):299-309. PubMed ID: 26907696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of exhaled particles from the healthy human lung--a systematic analysis in relation to pulmonary function variables.
    Schwarz K; Biller H; Windt H; Koch W; Hohlfeld JM
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):371-9. PubMed ID: 20500095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled particles as markers of small airway inflammation in subjects with asthma.
    Larsson P; Lärstad M; Bake B; Hammar O; Bredberg A; Almstrand AC; Mirgorodskaya E; Olin AC
    Clin Physiol Funct Imaging; 2017 Sep; 37(5):489-497. PubMed ID: 26648443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of particle size on regional lung deposition--what evidence is there?
    Carvalho TC; Peters JI; Williams RO
    Int J Pharm; 2011 Mar; 406(1-2):1-10. PubMed ID: 21232585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of non-spherical particles in bifurcating airways.
    Bunchatheeravate P; Curtis JS
    Pharm Dev Technol; 2014 Dec; 19(8):942-51. PubMed ID: 24320756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of the deposition of aerosol particles in the respiratory tract of the rat. II. Hygroscopic particle deposition.
    Ferron GA; Upadhyay S; Zimmermann R; Karg E
    J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):101-19. PubMed ID: 23550602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.
    Glover W; Chan HK; Eberl S; Daviskas E; Verschuer J
    Int J Pharm; 2008 Feb; 349(1-2):314-22. PubMed ID: 17904774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator.
    Biddiscombe MF; Barnes PJ; Usmani OS
    J Aerosol Med; 2006; 19(3):245-53. PubMed ID: 17034300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inspiratory and expiratory aerosol deposition in the upper airway.
    Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS
    Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of calculating lung delivery and deposition of aerosol particles.
    Kim CS
    Respir Care; 2000 Jun; 45(6):695-711. PubMed ID: 10894462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.
    Devadason SG; Chan HK; Haeussermann S; Kietzig C; Kuehl PJ; Newman S; Sommerer K; Taylor G
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S6-9. PubMed ID: 23215848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size distribution of a suspension aerosol using Andersen and Marple-Miller cascade impactors.
    Rao GN; Banick DW; Pacenti DM
    Pharm Res; 1997 Sep; 14(9):1272-4. PubMed ID: 9327461
    [No Abstract]   [Full Text] [Related]  

  • 20. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.